BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23595220)

  • 1. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
    Peng H; Xie SK; Huang MJ; Ren DL
    Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.
    Xu L; Yang M; Zhao T; Jin H; Xu Z; Li M; Chen H
    Medicine (Baltimore); 2014 Dec; 93(27):e178. PubMed ID: 25501063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
    Zhou GW; Hu J; Li Q
    World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CYP2E1 polymorphisms and colorectal cancer risk: a systematic review and meta-analysis.
    Sharzehan MAK; Sito H; Abdullah N; Alexiou A; Papadakis M; Jamal R; Tan SC
    Sci Rep; 2022 Nov; 12(1):20149. PubMed ID: 36418904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
    Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
    Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meta-analysis on association between genetic polymorphisms of cytochrome P450 2E1 and susceptibility to Chinese gastric cancer].
    Mi Y; Liang X; Wu J
    Wei Sheng Yan Jiu; 2018 May; 47(3):476-481. PubMed ID: 30082020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
    Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
    Zhuo W; Zhang L; Wang Y; Ling J; Zhu B; Chen Z
    PLoS One; 2012; 7(11):e48265. PubMed ID: 23139769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
    Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
    PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
    Guo Y; Zhou S; Liu F; Zhang B
    Int J Clin Exp Pathol; 2015; 8(11):14685-92. PubMed ID: 26823792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis.
    Zeng T; Guo FF; Zhang CL; Song FY; Zhao XL; Xie KQ
    PLoS One; 2013; 8(1):e54188. PubMed ID: 23335995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.
    Qian J; Song Z; Lv Y; Huang X
    Tumour Biol; 2013 Aug; 34(4):2225-31. PubMed ID: 23636797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
    Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
    Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis.
    Fu P; Yang F; Li B; Zhang B; Guan L; Sheng J; Ye Y; Wang Z; Li P; Xu L; Zou L; Li W
    Dig Liver Dis; 2017 Jan; 49(1):77-83. PubMed ID: 27637154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis.
    Fang Z; Wu Y; Zhang N
    Oncotarget; 2017 Oct; 8(49):86853-86864. PubMed ID: 29156840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.
    Gao CM; Takezaki T; Wu JZ; Chen MB; Liu YT; Ding JH; Sugimura H; Cao J; Hamajima N; Tajima K
    World J Gastroenterol; 2007 Nov; 13(43):5725-30. PubMed ID: 17963298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the role of rs2031920 and rs3813867 polymorphisms within the
    Zhang H; Li H; Yu H
    Cancer Cell Int; 2018; 18():67. PubMed ID: 29743817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.
    Jiang O; Zhou R; Wu D; Liu Y; Wu W; Cheng N
    Tumour Biol; 2013 Apr; 34(2):1215-24. PubMed ID: 23355335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2E1 rs2031920, COMT rs4680 Polymorphisms, Cigarette Smoking, Alcohol Use and Lung Cancer Risk in a Japanese Population.
    Kakino K; Kiyohara C; Horiuchi T; Nakanishi Y
    Asian Pac J Cancer Prev; 2016; 17(8):4063-70. PubMed ID: 27644662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
    Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
    J Cell Mol Med; 2015 Sep; 19(9):2136-42. PubMed ID: 25945422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.